Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

Cold water has been tossed on the idea that CVS Health would break up the company and sell off health or pharmacy benefits from assets that provide medical care. In his first earnings call following a ...

Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various ...

The pharmacy benefit managers, which were named in two of the complaints—CVS Caremark, Express Scripts, MedImpact, and ...

CVS did not break out separate enrollment figures for fully insured group health plans when it posted its earnings.

TD Cowen analyst Charles Rhyee maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $85.00. The ...

CVS Health today announced Prem Shah will be group president, and will continue to report to David Joyner, president and CEO. In addition, the company announced the appointment of Steve Nelson as ...

CVS Health reported $87 million in net income in the third quarter, down from nearly $2.3 billion year over year. Total revenue in Q3 was $95.4 billion, up 6.3% from the same time period last year.

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...